These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28266098)

  • 1. Characteristics and outcomes of patients undergoing percutaneous coronary intervention within 1 year of coronary artery bypass graft surgery.
    Sharma D; Kotowycz MA; Sharma V; Choudhury A; Chan W; Freixa X; Džavík V; Overgaard CB
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):186-193. PubMed ID: 28266098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
    Brilakis ES; O'Donnell CI; Penny W; Armstrong EJ; Tsai T; Maddox TM; Plomondon ME; Banerjee S; Rao SV; Garcia S; Nallamothu B; Shunk KA; Mavromatis K; Grunwald GK; Bhatt DL
    JACC Cardiovasc Interv; 2016 May; 9(9):884-93. PubMed ID: 27085582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.
    Varghese I; Samuel J; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2009; 10(2):103-9. PubMed ID: 19327672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
    Brilakis ES; Rao SV; Banerjee S; Goldman S; Shunk KA; Holmes DR; Honeycutt E; Roe MT
    JACC Cardiovasc Interv; 2011 Aug; 4(8):844-50. PubMed ID: 21851896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG.
    Mavroudis CA; Kotecha T; Chehab O; Hudson J; Rakhit RD
    Int J Cardiol; 2017 Feb; 228():563-569. PubMed ID: 27875735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left main coronary artery stenosis: a meta-analysis of drug-eluting stents versus coronary artery bypass grafting.
    Athappan G; Patvardhan E; Tuzcu ME; Ellis S; Whitlow P; Kapadia SR
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1219-30. PubMed ID: 24355112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Watanabe H; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Tazaki J; Watanabe H; Natsuaki M; Minatoya K; Hanyu M; Komiya T; Kimura T;
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):42-51. PubMed ID: 31389659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior Coronary Artery Bypass Graft Surgery and Outcome After Percutaneous Coronary Intervention: An Observational Study From the Pan-London Percutaneous Coronary Intervention Registry.
    Rathod KS; Beirne AM; Bogle R; Firoozi S; Lim P; Hill J; Dalby MC; Jain AK; Malik IS; Mathur A; Kalra SS; DeSilva R; Redwood S; MacCarthy PA; Wragg A; Smith EJ; Jones DA
    J Am Heart Assoc; 2020 Jun; 9(12):e014409. PubMed ID: 32475202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial.
    Giustino G; Serruys PW; Sabik JF; Mehran R; Maehara A; Puskas JD; Simonton CA; Lembo NJ; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Ragosta M; Kron IL; Liu Y; Zhang Z; McAndrew T; Dressler O; Généreux P; Ben-Yehuda O; Pocock SJ; Kappetein AP; Stone GW
    JACC Cardiovasc Interv; 2020 Feb; 13(3):375-387. PubMed ID: 31954680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
    Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.
    Wei Z; Xie J; Wang K; Kang L; Dai Q; Bai J; Xu B
    Int Heart J; 2016 Dec; 57(6):682-688. PubMed ID: 27829638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Welsh RC; Granger CB; Westerhout CM; Blankenship JC; Holmes DR; O'Neill WW; Hamm CW; Van de Werf F; Armstrong PW;
    JACC Cardiovasc Interv; 2010 Mar; 3(3):343-51. PubMed ID: 20298996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.